Sleep problems are very common in children with early-life epilepsy.
In children presenting with DEEs, genetic diagnoses can be made in over 50% of cases and inform precision medicine approaches to treatment.
Using computational analysis common symptoms for 5 phenotypes of SCN2A were found. The model also predicted gain & loss of function variants.
Natural history studies are critical for clinical trial design & registration of new treatments for developmental epileptic encephalopathies.
This study showed a direct relationship between autism behaviour and SCN2A loss of function mutation in a mouse model.
This study found behaviour abnormalities in SCN2A mouse models that can be used to assess the effectiveness of new treatments.
Gene-based therapy using ASO-mediated mRNA was very effective in a mouse model of SCN2A.
Having a child with genetic epilepsy has a significant impact on parents. Health services need to recognise parent’s needs.
Hear the latest on genetic epilepsy from world-leading experts at Genetic Epilepsy Family Conference, May 29th 2021.
Dr Emma Palmer discusses how to decipher your genetic reports – what should be included and what does it mean?